EU health regulator warns some hep C drugs could reactivate hep B
December 02, 2016 at 10:07 AM EST
Dec 2 (Reuters) - The European Medicines Agency warned on Friday that some of the most successful hepatitis C treatments on the market could reactivate hepatitis B in patients.